NCT05897775

Brief Summary

Deep brain stimulation (DBS) is a surgical procedure for the treatment of Essential Tremor (ET). A novel approach to current DBS approaches is called coordinated reset DBS (CR-DBS) which uses different patterns of stimulation at lower currents and can address the limitations of traditional DBS that uses continuous high amplitude, high frequency stimulation. This study will evaluate the feasibility, safety and short-term efficacy of thalamic CR-DBS in upper extremity ET. The goal of this study is to evaluate the safety and short-term efficacy of thalamic CR- DBS in ET, including the acute (during CR-DBS) and carryover (following DBS cessation) effects, and compare these to those induced by clinically optimized T-DBS. To achieve our goal, a low-risk, two-phase clinical study will be conducted in patients with upper extremity (UE) ET. The first aim is to identify the spatial location and peak frequency of tremor related oscillatory activities in VIM (Phase I). The second aim is to compare the acute effects of thalamic CR-DBS to clinically optimized T-DBS (Phase II).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at P25-P50 for phase_1

Timeline
33mo left

Started Sep 2023

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Sep 2023Dec 2028

First Submitted

Initial submission to the registry

June 1, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 9, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

September 11, 2023

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

4.8 years

First QC Date

June 1, 2023

Last Update Submit

November 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Tremor Research Group Essential Tremor Rating Scale (TETRAS)

    TETRAS is a rating scale introduced by the Tremor Research Group which has undergone extensive performance evaluations7. The TETRAS Activities of Daily Living Subscale (TETRAS-ADL) rates tremor's impact on activities of daily living, using 12 test items with each item scored from 0-4 (increasing with severity). The TETRAS-ADL total score range is 0-48. The TETRAS performance subscale (TETRAS-P) consists of 16 scored items designed to measure essential tremor of the head, face, voice, upper extremity, lower extremity and trunk, with each item scored from 0-4 (increasing with severity). Specific amplitude measurements are used to guide the ratings for each item. Tasks of spiral drawing, handwriting and object holding are included. The TETRAS-P total score range is 0-64. The total TETRAS score, including both TETRAS-ADL and TETRAS-P, ranges from 0 to 112.

    4 months

Secondary Outcomes (8)

  • Instrumented Tremor Measurement

    4 months

  • Bain Tremor Disability Scale (BTDS)

    4 months

  • Quality of Life in Essential Tremor (QUEST)

    4 months

  • Quantitative Archimedes Spirals

    4 months

  • Dot Approximation Task

    4 months

  • +3 more secondary outcomes

Study Arms (2)

Coordinated Reset DBS Setting (CR-DBS)

EXPERIMENTAL

Coordinated Reset DBS settings

Device: Deep brain stimulation

Clinically Optimized DBS Setting (T-DBS)

OTHER

Traditional DBS settings

Device: Deep brain stimulation

Interventions

Thalamic coordinated reset DBS (CR-DBS) which uses different patterns of stimulation at lower currents and can address the limitations of traditional DBS (T-DBS) that uses continuous high amplitude, high frequency stimulation. Each participant will receive both the new intervention and the standard of care intervention, each for a week.

Clinically Optimized DBS Setting (T-DBS)Coordinated Reset DBS Setting (CR-DBS)

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of essential tremor (ET)
  • Age of 21 or over
  • Will be or has been implanted with Boston Scientific Vercise Rechargeable Genus deep brain stimulation (DBS) system
  • Tesla (7T) MRI pre-operative scan under Noam Harel PhD's Center for Magnetic Research (University of Minnesota IRB #1210M22183) protocol "Imaging of DBS targets at 7T MRI"
  • Planned post-operative CT scan

You may not qualify if:

  • History of musculoskeletal disorders that affect movement of the limbs or gait
  • Other significant neurological disorder
  • History of dementia or cognitive impairment that precludes them from getting DBS surgery
  • Significant psychiatric disease
  • On medication that could cause tremor
  • Prior brain surgery
  • Pregnant women
  • Evidence of non-ET central nervous system disease or injury for at least three (3) months prior to implantation
  • Any suspicion of Parkinsonian tremor, including presence of Parkinsonian features such as bradykinesia, rigidity, or postural instability
  • Other significant medical disorder that could impede study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota

Minneapolis, Minnesota, 55455, United States

RECRUITING

MeSH Terms

Conditions

Essential Tremor

Interventions

Deep Brain Stimulation

Condition Hierarchy (Ancestors)

Movement DisordersCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsSurgical Procedures, Operative

Study Officials

  • Jing Wang, PhD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jing Wang, PhD

CONTACT

Johanna Caskey

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants will be blinded to the order of interventions they receive. The investigators assessing the severity of tremor and side effects through videos will also be blinded to the intervention condition.
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Each participant will receive both the new intervention which is a new stimulation pattern and the standard of care intervention, each for a week.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 1, 2023

First Posted

June 9, 2023

Study Start

September 11, 2023

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

November 28, 2025

Record last verified: 2025-11

Locations